Geron Corporation share price logo

Geron Corporation Share Price

NASDAQ: GERN

Small Cap

$1.69

(+-0.30%)

as on

Geron Corporation Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.66
    $1.74
    downward going graph

    1.78%

    Downside

    2.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.04
    $2.01
    downward going graph

    38.46%

    Downside

    18.93%

    Upside

    downward going graph

Geron Corporation share price movements today

Previous Close
$1.69
Open
$1.72
Volume
27.4M
Day's Low - High
$1.66 - $1.74
52 Week Low - High
$1.04 - $2.01

Geron Corporation Historical Returns

1 Month Return
+ 4.32 %
3 Month Return
+ 29.01 %
1 Year Return
+ 33.07 %
3 Year Return
-17.56 %
5 Year Return
+ 14.97 %

Geron Corporation Stock Fundamentals & Key Indicators

Check Geron Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-2.38

EBITDA

-51.1M

Revenue (TTM)

183.9M

Profit Margin

-45.41%

Return On Equity TTM

-32.99%

Geron Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Geron Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Geron Corporation image
Geron Corporation
BUY$1.1B14.97%NA-45.41%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Stock Returns calculator for Geron Corporation Stock including INR - Dollar returns

The Geron Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Geron Corporation investment value today

Current value as on today

₹1,44,569

Returns

₹44,569

(+44.57%)

Returns from Geron Corporation Stock

₹33,071 (+33.07%)

Dollar Impact

₹11,498 (+11.5%)

Analyst Recommendation on Geron Corporation Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Geron Corporation. Average target price of $3.4

Geron Corporation Share Price Target

Get share price movements and forecasts by analysts on Geron Corporation.

What analysts predicted

50.29%UPSIDE

Target Price

$3.4

Current Price

$1.69

Analyzed by

13 Analysts

Target

$3.40

Geron Corporation target price $3.4, a slight upside of 50.29% compared to current price of $1.69. According to 13 analysts rating.

Geron Corporation Stock’s Investor Sentiment and Interest

Search interest for Geron Corporation Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

Geron Corporation Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
28
47
39
49
47
48
Gross Profit
0
0
0
0
27
46
38
47
25
46
Operating Income
-47
-54
-56
-69
-28
-20
-16
-12
-13
-10
EBITDA
-42
-49
-51
-63
-23
-16
-11
-7
-9
-23
Interest Expense
2
2
3
3
3
8
8
8
8
7
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-44
-51
-55
-67
-26
-25
-19
-16
-18
-31
Income Tax Expense
0
0
0
-
-26
-
-
-
-
-
Net Income
-44
-51
-55
-67
-26
-25
-19
-16
-18
-31
Net Profit Margin
-27320.12%
-225969.57%
-18220.39%
-7639.80%
-93.55%
-53.33%
-50.08%
-33.39%
-39.02%
-64.86%

Geron Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
1
1
0
0
1
0
0
76
183
Gross Profit
-8
-7
-11
0
-49
1
0
0
75
179
Operating Income
-30
-29
-31
-72
-76
-113
-138
-193
-173
-53
EBITDA
-30
-29
-26
-71
-76
-111
-134
-174
-154
-51
Interest Expense
0
0
-
-
0
3
6
8
18
32
Depreciation
-
0
0
0
0
0
0
1
1
1
Income Before Tax
-29
-27
-27
-68
-75
-116
-141
-184
-174
-85
Income Tax Expense
1
1
4
-4
0
4
0
0
-
-
Net Income
-29
-27
-27
-63
-75
-116
-141
-184
-174
-85
Net Profit Margin
-479.34%
-2621.22%
-2534.43%
-13815.43%
-29888.14%
-8335.39%
-23808.89%
-77690.72%
-226.73%
-46.65%

Geron Corporation Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-51
-55
-67
-26
-25
-19
-16
-18
-28
Operating Cash Flow
-40
-62
-53
-58
-43
-47
-27
-13
-22
Investing Cash Flow
47
34
-36
0
-103
52
20
13
21
Financing Cash Flow
33
147
16
3
166
0
1
0
0
Change in Cash
39
119
-72
-55
18
4
-6
0
0

Geron Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-27
-68
-75
-116
-141
-184
-174
-85
Operating Cash Flow
-20
-21
-43
-66
-95
-127
-167
-218
-111
Investing Cash Flow
22
-77
27
-105
71
62
-180
-106
107
Financing Cash Flow
1
92
19
168
48
87
362
334
2
Change in Cash
3
-5
3
-3
24
21
13
9
-1

Global Institutional Holdings in Geron Corporation

Funds
Holdings
Citadel Advisors Llc
2.45%
Eversept Partners, LP
2.76%
FMR Inc
1.26%
Geode Capital Management, LLC
2.05%
Woodline Partners LP
1.17%
See all

Insights on Geron Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 47.22M → 48.01M (in $), with an average increase of 1.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, GERN stock has moved up by 29.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 5.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 38.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -16.37M → -31.14M (in $), with an average decrease of 40.8% per quarter

About Geron Corporation

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
OrganisationGeron Corporation
Headquarters919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
IndustryBiotechnology
CEOMr. Harout Semerjian
E-voting on sharesClick here to vote

Key Management of Geron Corporation

Name

Title

Mr. Harout Semerjian

CEO, President & Director

Dr. Joseph Emile Eid M.D.

Executive VP of Research & Development and Chief Medical Officer

Mr. Ahmed ElNawawi

Executive VP & Chief Commercial Officer

Mr. Shanthakumar Tyavanagimatt

Senior VP & Chief Technical Officer

Ms. Dawn Schottlandt CFA

Senior Vice President of Investor Relations & Corporate Affairs

FAQs

What is Geron Corporation share price today?

Geron Corporation share price today is $1.69 as on at the close of the market. Geron Corporation share today touched a day high of $1.74 and a low of $1.66.

What is the 52 week high and 52 week low for Geron Corporation share?

Geron Corporation share touched a 52 week high of $2.01 on and a 52 week low of $1.04 on . Geron Corporation stock price today i.e. is closed at $1.69,which is 15.92% down from its 52 week high and 62.50% up from its 52 week low.

What is Geron Corporation's market capitalisation today?

Geron Corporation market capitalisation is $0.00T as on .

How to invest in Geron Corporation Stock (GERN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Geron Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Geron Corporation Shares that will get you 0.8876 shares as per Geron Corporation share price of $1.69 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Geron Corporation Stock (GERN) from India?

Indian investors can start investing in Geron Corporation (GERN) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Geron Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Geron Corporation share’s latest price of $1.69 as on April 18, 2026 at 1:29 am IST, you will get 5.9172 shares of Geron Corporation. Learn more about fractional shares .

What are the returns that Geron Corporation has given to Indian investors in the last 5 years?

Geron Corporation stock has given 14.97% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?